Search companies or stocks...
CTSOCytosorbents Corporation
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a…
Current stock price of Cytosorbents Corporation (CTSO) stock is $0.380. The stock price is +13.55% higher in the session. The intraday range can be seen from this page. Volume of Cytosorbents Corporation (CTSO) stock is 5.62M.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Cytosorbents Corporation (CTSO) can change with earnings, company news, and overall market sentiment. Cytosorbents Corporation operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Cytosorbents Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CTSO on this page is -1.37. EPS on this page is -0.28. Compare those figures with peers and growth expectations before deciding if the current Cytosorbents Corporation price is justified.
Historical performance for Cytosorbents Corporation (CTSO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CTSO reacted to past earnings and market events.
Buying Cytosorbents Corporation (CTSO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
